These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15334239)

  • 1. Axoval neuropathy as initial manifestation of primary amyloidosis: report of a case submitted to bone marrow transplantation.
    Barsottini OG; Arantes A; Sigulem D; Kutner JM; Ribeiro AA; Moura LA; Hamerschlak N
    Arq Neuropsiquiatr; 2004 Sep; 62(3A):725-9. PubMed ID: 15334239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic bone marrow transplantation for AL amyloidosis.
    Guillaume B; Straetmans N; Jadoul M; Cosyns JP; Ferrant A
    Bone Marrow Transplant; 1997 Nov; 20(10):907-8. PubMed ID: 9404936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of nephrotic syndrome due to systemic AL amyloidosis after autologous stem cell transplantation: renal response is an important therapeutic end point.
    Akay OM; Sahin G; Kabukcuoglu S; Yalcin AU; Gulbas Z
    Clin Nephrol; 2008 Apr; 69(4):294-7. PubMed ID: 18397705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy.
    Rajkumar SV; Gertz MA; Kyle RA
    Am J Med; 1998 Mar; 104(3):232-7. PubMed ID: 9552085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotic syndrome due to primary AL amyloidosis, successfully treated with VAD and subsequent high-dose melphalan followed by autologous peripheral blood stem cell transplantation.
    Gono T; Matsuda M; Dohi N; Hoshi K; Tada T; Sakashita K; Koike K; Aizawa M; Ikeda S
    Intern Med; 2003 Jan; 42(1):72-7. PubMed ID: 12583623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose therapy and autologous transplantation in amyloidosis-AL.
    Majolino I; Marcenò R; Pecoraro G; Scimé R; Vasta S; Liberti G; Rizzo A; Indovina A; Caronia F
    Haematologica; 1993; 78(1):68-71. PubMed ID: 8098314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloidotic muscle pseudohypertrophy: case report.
    Scola RH; Werneck LC; Ramos CS; Pasquini R; Graf H; Arruda WO
    Arq Neuropsiquiatr; 2001 Sep; 59(3-A):582-6. PubMed ID: 11588639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary systemic amyloidosis presenting as a colonic stricture: successful treatment with left hemicolectomy followed by autologous hematopoietic stem-cell transplantation: report of a case.
    Rives S; Pera M; Rosiñol L; Vidal O; Miquel R; Solé M; García-Valdecasas J; Bladé J
    Dis Colon Rectum; 2002 Sep; 45(9):1263-6. PubMed ID: 12352247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic megacolon: a life-threatening complication of high-dose therapy and autologous stem cell transplantation among patients with AL amyloidosis.
    Hayes-Lattin BM; Curtin PT; Fleming WH; Leis JF; Stepan DE; Schubach S; Maziarz RT
    Bone Marrow Transplant; 2002 Sep; 30(5):279-85. PubMed ID: 12209349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease.
    Dember LM; Sanchorawala V; Seldin DC; Wright DG; LaValley M; Berk JL; Falk RH; Skinner M
    Ann Intern Med; 2001 May; 134(9 Pt 1):746-53. PubMed ID: 11329232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of AL amyloidosis.
    Sezer O; Eucker J; Jakob C; Possinger K
    Clin Nephrol; 2000 Jun; 53(6):417-23. PubMed ID: 10879660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL).
    Gertz MA; Lacy MQ; Gastineau DA; Inwards DJ; Chen MG; Tefferi A; Kyle RA; Litzow MR
    Bone Marrow Transplant; 2000 Nov; 26(9):963-9. PubMed ID: 11100275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New elements in the diagnosis and the treatment of primary AL amyloid polyneuropathy and neuropathy due to POEMS syndrome].
    Adams D; Lozeron P; Theaudin M; Ribrag V; Bourhis JH; Lacroix C
    Rev Neurol (Paris); 2011 Jan; 167(1):57-63. PubMed ID: 21190703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
    Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
    Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosis.
    Dingli D; Tan TS; Kumar SK; Buadi FK; Dispenzieri A; Hayman SR; Lacy MQ; Gastineau DA; Hogan WJ; Gertz MA
    Neurology; 2010 Mar; 74(11):913-8. PubMed ID: 20231668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal perforation early after peripheral blood stem cell transplantation for AL amyloidosis.
    Schulenburg A; Kalhs P; Oberhuber G; Reiter E; Base W; Greinix HT
    Bone Marrow Transplant; 1998 Aug; 22(3):293-5. PubMed ID: 9720746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of biopsy-proven leptomeningeal amyloidosis and intravenous Ig-responsive polyneuropathy associated with the Ala25Thr transthyretin gene mutation.
    Shimizu Y; Takeuchi M; Matsumura M; Tokuda T; Iwata M
    Amyloid; 2006 Mar; 13(1):37-41. PubMed ID: 16690499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic AA amyloidosis manifested by autonomic neuropathy, vestibulocochleopathy, and lattice corneal dystrophy.
    Tsunoda I; Awano H; Kayama H; Tsukamoto T; Ueno S; Fujiwara T; Watanabe M; Yamamoto T
    J Neurol Neurosurg Psychiatry; 1994 May; 57(5):635-7. PubMed ID: 8201343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation.
    Reich G; Held T; Siegert W; Kampf D; Dörken B; Maschmeyer G
    Bone Marrow Transplant; 2001 Feb; 27(3):341-3. PubMed ID: 11277185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.